Dizdar Oguzhan Sitki, Ersoy Alparslan, Akalin Halis
Department of Internal Medicine, Afsin State Hospital, Kahramanmaras, Turkey.
Exp Clin Transplant. 2014 Jun;12(3):205-11.
Pneumonia is an important cause of morbidity and mortality in recipients of solid-organ transplant. We aimed to determine risk factors for development of pneumonia and associated deaths in kidney transplant recipients.
A retrospective review of medical records was performed for all kidney transplant recipients from December 1988, to April 2011. The diagnosis of community-acquired pneumonia was made from symptoms, clinical findings, and chest radiography. The diagnosis of nosocomial pneumonia was made according to published criteria. Laboratory and serologic tests, radiographic findings, cultures of respiratory specimens, and tissue biopsies were reviewed.
In 406 kidney transplant recipients, there were 82 patients (20%) who had 111 episodes of pneumonia, including 49 nosocomial episodes of pneumonia (44%). Bacterial infections were the most common cause (34 episodes [31%]). In multivariate analysis, significant risk factors associated with pneumonia episodes were older age, hypertension, cardiac disease, history of acute graft rejection, and not using everolimus/mycophenolate mofetil/prednisolone protocol. There were 28 episodes that resulted in death (25%), including 20 nosocomial episodes (71%). In multivariate analysis, significant risk factors associated with death from pneumonia episodes were antibiotic use in the previous 3 months, high C-reactive protein, and low albumin. Cutoff values for increased risk of death from pneumonia included C-reactive protein > 10 mg/dL and procalcitonin > 8.8 ng/mL.
Recipients of kidney transplant may be at risk for pneumonia and associated death. Nosocomial pulmonary infections may be associated with marked morbidity and mortality in kidney transplant recipients.
肺炎是实体器官移植受者发病和死亡的重要原因。我们旨在确定肾移植受者发生肺炎及相关死亡的危险因素。
对1988年12月至2011年4月期间所有肾移植受者的病历进行回顾性研究。根据症状、临床表现和胸部X线检查诊断社区获得性肺炎。医院获得性肺炎的诊断依据已发表的标准。对实验室和血清学检查、影像学检查结果、呼吸道标本培养及组织活检进行了回顾。
在406例肾移植受者中,有82例患者(20%)发生了111次肺炎发作,其中包括49次医院获得性肺炎发作(44%)。细菌感染是最常见的原因(34次发作[31%])。多因素分析显示,与肺炎发作相关的显著危险因素包括年龄较大、高血压、心脏病、急性移植排斥史以及未使用依维莫司/霉酚酸酯/泼尼松龙方案。有28次发作导致死亡(25%),其中包括20次医院获得性发作(71%)。多因素分析显示,与肺炎发作死亡相关的显著危险因素包括前3个月使用抗生素、高C反应蛋白和低白蛋白。肺炎死亡风险增加的临界值包括C反应蛋白>10mg/dL和降钙素原>8.8ng/mL。
肾移植受者可能有发生肺炎及相关死亡的风险。医院获得性肺部感染可能与肾移植受者的显著发病率和死亡率相关。